Preserve Access to Affordable Generics Act

Bill 111 s 369, also known as the Preserve Access to Affordable Generics Act, is a piece of legislation currently being considered by the US Congress. The main goal of this bill is to prevent pharmaceutical companies from engaging in anti-competitive practices that delay the entry of generic drugs into the market.

The bill specifically targets a practice known as "pay-for-delay," where brand-name drug manufacturers pay generic drug manufacturers to delay the release of their generic versions of a drug. This practice can significantly increase the cost of prescription drugs for consumers, as generic drugs are typically much more affordable than their brand-name counterparts.

If passed, the Preserve Access to Affordable Generics Act would make it illegal for brand-name drug manufacturers to enter into agreements with generic drug manufacturers that delay the entry of generic drugs into the market. This would help to promote competition in the pharmaceutical industry and ensure that consumers have access to affordable medications. Overall, the bill aims to protect consumers from high drug prices and promote a more competitive pharmaceutical market. It is currently being debated in Congress, and its passage could have a significant impact on the affordability of prescription drugs for Americans.